WORLDSymposia (@worldsymposia) 's Twitter Profile
WORLDSymposia

@worldsymposia

We're Organizing Research on Lysosomal Diseases

ID: 2790591038

linkhttp://www.worldsymposia.org calendar_today04-09-2014 20:48:51

849 Tweet

945 Takipçi

363 Takip Edilen

WORLDSymposia (@worldsymposia) 's Twitter Profile Photo

WORLDSymposium announces James M. Wilson, MD, PhD, President and CEO of GEMMA Biotherapeutics, to receive the 2025 Roscoe O. Brady Award on Tuesday, February 4, 2025 at 08:00 PST. worldsymposia.org/worldsymposium… #WORLDSymposia #RareDisease #CareAboutRare

WORLDSymposia (@worldsymposia) 's Twitter Profile Photo

Please Share: WORLDSymposium 2025 Late-breaking Call for Abstracts Now Open. #WORLDSymposia will be accepting late-breaking abstracts from Nov. 1 to Dec. 2, 2024 for poster presentation & possible platform presentation. More at worldsymposia.org/worldsymposium… #RareDisease #CareAboutRare

WORLDSymposia (@worldsymposia) 's Twitter Profile Photo

Congratulations to the ten individuals selected to receive the WORLDSymposium 2025 Young Investigator Award. Visit worldsymposia.org/worldsymposium… to see the list of award recipients. #WORLDSymposia #RareDiseases #CareAboutRare

WORLDSymposia (@worldsymposia) 's Twitter Profile Photo

Late-breaking Abstract Submission closing next Monday, Dec. 2 - Only 5 days left to submit late-breaking abstracts and last chance to have platform presentation at WORLDSymposium 2025. Visit worldsymposia.org/worldsymposium… to submit your abstracts today! #WORLDSymposia #LysosomalDisease

WORLDSymposia (@worldsymposia) 's Twitter Profile Photo

#WORLDSymposia Late-breaking abstract submission closes today, December 2, 2024 at 12:00 CST. This is the last opportunity to submit abstracts for poster and/or presentation at WORLDSymposium 2025. Submit abstracts today: worldsymposia.org/worldsymposium… #RareDiseases #LysosomalDisease

WORLDSymposia (@worldsymposia) 's Twitter Profile Photo

WORLDSymposium announces Ryan Colburn to receive the 2025 Catalyst Award. Ryan will receive the 2nd Annual Catalyst Award at the Be the Catalyst event at 18:00 PST on Monday, February 3, 2025. worldsymposia.org/worldsymposium… #WORLDSymposia #RareDisease #Lysosomal Disease

WORLDSymposia (@worldsymposia) 's Twitter Profile Photo

Early Registration for #WORLDSymposia 2025 closes Monday, January 6, 2025. This includes reduced rates for The Patient Voice 2025 and On Demand. Click here to register: cvent.me/Ll4oYm #CareAboutRare #RareDiseases #LysosomalDisease

WORLDSymposia (@worldsymposia) 's Twitter Profile Photo

#WORLDSymposia 2025 Poster List Now Online. Over 400 abstracts will be presented at three poster sessions. Excellent opportunity to see, hear & discuss specific research topics directly with authors. #LysosomalDisease #CareAboutRare #RareDiseases worldsymposia.org/?p=94

WORLDSymposia (@worldsymposia) 's Twitter Profile Photo

#WORLDSymposia celebrated a pivotal moment, presenting the 2nd Annual "Catalyst" award to Ryan Colburn in recognition of his efforts to instigate a shift in perspective for the prevalence of Pompe disease #RareDiseases #LysosomalDisease #CareAboutRare

#WORLDSymposia celebrated a pivotal moment, presenting the 2nd Annual "Catalyst" award to Ryan Colburn in recognition of his efforts to instigate a shift in perspective for the prevalence of Pompe disease #RareDiseases #LysosomalDisease #CareAboutRare
WORLDSymposia (@worldsymposia) 's Twitter Profile Photo

Dr. James M. Wilson was awarded the 2025 Roscoe O. Brady Award at #WORLDSymposia on Feb 4. Recognized as a global leader in gene therapy research and development. Congratulations, Dr. Wilson! #RareDiseases #LysosomalDisease #CareAboutRare

Dr. James M. Wilson was awarded the 2025 Roscoe O. Brady Award at #WORLDSymposia on Feb 4. Recognized as a global leader in gene therapy research and development. Congratulations, Dr. Wilson! #RareDiseases #LysosomalDisease #CareAboutRare
WORLDSymposia (@worldsymposia) 's Twitter Profile Photo

Congratulations to Maria Kefalas, the recipient of the #WORLDSymposium 2025 Patient Advocate Leader Award! Maria's mission to get an approved therapy for MLD has been instrumental in transforming MLD research. #RareDiseases #LysosomalDisease

Congratulations to Maria Kefalas, the recipient of the #WORLDSymposium 2025 Patient Advocate Leader Award! Maria's mission to get an approved therapy for MLD has been instrumental in transforming MLD research. #RareDiseases #LysosomalDisease
WORLDSymposia (@worldsymposia) 's Twitter Profile Photo

Congratulations to Dean & Teryn Suhr, the recipient of the #WORLDSymposia 2025 Patient Advocate Leader Award! The Suhrs' were recognized for their tireless efforts to advance metachromatic leukodystrophy research and awareness. #RareDiseases #LysosomalDisease

Congratulations to Dean & Teryn Suhr, the recipient of the #WORLDSymposia 2025 Patient Advocate Leader Award! The Suhrs' were recognized for their tireless efforts to advance metachromatic leukodystrophy research and awareness. #RareDiseases #LysosomalDisease
WORLDSymposia (@worldsymposia) 's Twitter Profile Photo

Congratulations to the 2025 #WORLDSymposia Young Investigator Award rcpts: Pratikshya Adhikari, Aimee Donald, Allan Feng, Angelica Maria Herreno Pachon,  Andres Felipe Leal, Connor Lewis, Anna Reinelt, Krystyna Noelle Rytel, Roselena Schuh & Ewa Ziolkowska worldsymposia.org/worldsymposium…

Congratulations to the 2025 #WORLDSymposia Young Investigator Award rcpts: Pratikshya Adhikari, Aimee Donald, Allan Feng, Angelica Maria Herreno Pachon,  Andres Felipe Leal, Connor Lewis, Anna Reinelt, Krystyna Noelle Rytel, Roselena Schuh & Ewa Ziolkowska worldsymposia.org/worldsymposium…
WORLDSymposia (@worldsymposia) 's Twitter Profile Photo

2025 #WORLDSymposia New Treatment Award was presented to IntraBio for the FDA approval of AQNEURSA™ (levacetylleucine) for the treatment of neurological manifestations of #NiemannPick disease type C (NPC) in adults and peds weighing ≥15 kg. tinyurl.com/2p8b5uuc #RareDiseases

2025 #WORLDSymposia New Treatment Award was presented to IntraBio for the FDA approval of AQNEURSA™ (levacetylleucine) for the treatment of neurological manifestations of #NiemannPick disease type C (NPC) in adults and peds weighing ≥15 kg. tinyurl.com/2p8b5uuc #RareDiseases
WORLDSymposia (@worldsymposia) 's Twitter Profile Photo

2025 #WORLDSymposia New Treatment Award was presented to Orchard Therapeutics for receiving FDA Approval of LENMELDY™ (atidarsagene autotemcel) for the treatment of children with PSLI, PSEJ, or ESEJ (collectively early-onset #MLD) tinyurl.com/2p8b5uuc #RareDiseases

2025 #WORLDSymposia New Treatment Award was presented to Orchard Therapeutics for receiving FDA Approval of LENMELDY™ (atidarsagene autotemcel) for the treatment of children with PSLI, PSEJ, or ESEJ (collectively early-onset #MLD) tinyurl.com/2p8b5uuc #RareDiseases
WORLDSymposia (@worldsymposia) 's Twitter Profile Photo

2025 #WORLDSymposia New Treatment Award was presented to Zevra for FDA approval of MIPLYFFA™ (arimoclomol) capsules for use in combination w/ miglustat for neuro symptoms of #NiemannPick type C (NPC) in pts ≥2 yrs. tinyurl.com/2p8b5uuc #RareDiseases

2025 #WORLDSymposia New Treatment Award was presented to Zevra for FDA approval of MIPLYFFA™ (arimoclomol) capsules for use in combination w/ miglustat for neuro symptoms of #NiemannPick type C (NPC) in pts ≥2 yrs. tinyurl.com/2p8b5uuc #RareDiseases
WORLDSymposia (@worldsymposia) 's Twitter Profile Photo

Planning is underway for the 22nd Annual WORLDSymposium™, taking place February 2–6, 2026 in San Diego. This global meeting will highlight advances in lysosomal disease diagnosis, therapy, and translational research. Key dates: hubs.li/Q03t1zpN0 #WORLDSymposia

WORLDSymposia (@worldsymposia) 's Twitter Profile Photo

Sponsorship and exhibitor opportunities for WORLDSymposium™ 2026 are now available. Explore the prospectus and planning details. hubs.li/Q03vqc060 #WORLDSymposia #MedicalResearch #RareDisease

Sponsorship and exhibitor opportunities for WORLDSymposium™ 2026 are now available.

Explore the prospectus and planning details.
hubs.li/Q03vqc060

#WORLDSymposia #MedicalResearch #RareDisease
WORLDSymposia (@worldsymposia) 's Twitter Profile Photo

WORLDSymposium 2026 award nominations are now open. Nominate by September 3 for the: • Roscoe O. Brady Award • Patient Advocate Leader Award • New Treatment Award • Catalyst Award Details and nomination form: hubs.li/Q03y4JsT0

WORLDSymposium 2026 award nominations are now open. Nominate by September 3 for the:

• Roscoe O. Brady Award
• Patient Advocate Leader Award
• New Treatment Award
• Catalyst Award

Details and nomination form: hubs.li/Q03y4JsT0
WORLDSymposia (@worldsymposia) 's Twitter Profile Photo

Nominate by Sept 3 for WORLDSymposium 2026 awards: • Roscoe O. Brady • PAL • New Treatment • Catalyst Details: hubs.li/Q03CsDlv0 #WORLDSymposia #ScientificRecognition

Nominate by Sept 3 for WORLDSymposium 2026 awards:

• Roscoe O. Brady
• PAL
• New Treatment
• Catalyst

Details: hubs.li/Q03CsDlv0

#WORLDSymposia #ScientificRecognition